(Q84355014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

1 reference

Yosuke Sugimoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hideki Mochizuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hideaki Okumichi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Masaya Takumida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Michiya Takamatsu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Seiichi Kawamata

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Yoshiaki Kiuchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

4 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

1601-1609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20524132%20AND%20SRC:MED&resulttype=core&format=json

Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab

4 February 2020

cites work

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema

1 reference

12 December 2020

Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma

1 reference

12 December 2020

Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model

1 reference

12 December 2020

Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma

1 reference

12 December 2020

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

1 reference

12 December 2020

In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma

1 reference

12 December 2020

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma

1 reference

12 December 2020

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

1 reference

12 December 2020

Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma

1 reference

12 December 2020

Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy

1 reference

12 December 2020

Effects of bevacizumab (Avastin) on retinal cells in organotypic culture

1 reference

12 December 2020

Intravitreal bevacizumab in a patient with neovascular glaucoma.

1 reference

12 December 2020

Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma

1 reference

12 December 2020

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

1 reference

12 December 2020

Effect of anti-VEGF antibody on retinal ganglion cells in rats.

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

12 December 2020

Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma

1 reference

12 December 2020

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

1 reference

12 December 2020

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration

1 reference

12 December 2020

Intravitreal bevacizumab for filtering surgery

1 reference

12 December 2020

Regression of neovascular iris vessels by intravitreal injection of bevacizumab

1 reference

12 December 2020

Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection

1 reference

12 December 2020

Intracameral bevacizumab for iris rubeosis

1 reference

12 December 2020

Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion

1 reference

12 December 2020

Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma

1 reference

12 December 2020